Schrodinger Inc (SDGR) - Total Liabilities
Based on the latest financial reports, Schrodinger Inc (SDGR) has total liabilities worth $332.31 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SDGR cash flow conversion to assess how effectively this company generates cash.
Schrodinger Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how Schrodinger Inc's total liabilities have evolved over time, based on quarterly financial data. Check SDGR asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Schrodinger Inc Competitors by Total Liabilities
The table below lists competitors of Schrodinger Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WA1 Resources Ltd
AU:WA1
|
Australia | AU$5.67 Million |
|
Episil Holding
TWO:3707
|
Taiwan | NT$3.66 Billion |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
China | CN¥2.27 Billion |
|
Shanghai Bolex Food Technology Co. Ltd.
SHG:603170
|
China | CN¥489.69 Million |
|
First Watch Restaurant Group Inc
NASDAQ:FWRG
|
USA | $1.11 Billion |
|
Metro Healthcare Indonesia
JK:CARE
|
Indonesia | Rp1.17 Trillion |
|
WESTLIFE FOODWORLD LIMITED
NSE:WESTLIFE
|
India | Rs20.35 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down Schrodinger Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SDGR stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Schrodinger Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Schrodinger Inc (2017–2024)
The table below shows the annual total liabilities of Schrodinger Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $401.78 Million | +57.93% |
| 2023-12-31 | $254.40 Million | +5.70% |
| 2022-12-31 | $240.68 Million | +20.70% |
| 2021-12-31 | $199.40 Million | +63.12% |
| 2020-12-31 | $122.24 Million | -50.83% |
| 2019-12-31 | $248.59 Million | +29.28% |
| 2018-12-31 | $192.29 Million | +86.00% |
| 2017-12-31 | $103.38 Million | -- |
About Schrodinger Inc
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery … Read more